Galera raises $11M A round; Can Novo make liraglutide into obesity blockbuster?; Infinity shoots up on blood cancer data;

 @FierceBiotech: GSK employs mobile phones to up vaccination rates in Africa. Story | Follow @FierceBiotech

@JohnCFierce: Sofinnova reaps $312M for its dedicated life sciences fund. Wished we saw more of these. News | Follow @JohnCFierce

> Galera Therapeutics has raised an $11 million Series A round for its programs on cancer and fibrosis. The round was co-led by New Enterprise Associates and Novartis Venture Fund and includes Correlation Ventures. Release

> Shares of Infinity Pharmaceuticals ($INFI) shot up after it announced positive results from an early-stage study of IPI-145 for blood cancers. Its stock jumped 21%. Story

> Reuters covers Novo Nordisk's ($NVO) plans to make the diabetes drug liraglutide into a new therapy for the seriously obese, developing a premium pricing model that has the potential to add significantly to its revenue. Story

> The Fred Hutchinson Cancer Research Center and GlaxoSmithKline ($GSK) announced a partnership to develop therapeutics to treat an inherited form of muscular dystrophy. Release

Pharma News

@FiercePharma: AbbVie shares fall in first day of 'when-issued' trading. Story | Follow @FiercePharma

> KV, Hologic reach $60 million deal on Makena. News

> J&J's Zytiga gets expanded approval that could double sales. Story

> Pernix snatches struggling Somaxon for $25M. Article

Medical Device News

 @FierceMedDev: Exact Sciences heads to the FDA with cancer diagnostic. Story | Follow @FierceMedDev

@MarkHFierce: MIT's Robert Langer is at it again--using porcupine quills as a model for next-generation medical device needles. More | Follow @MarkHFierce

 @DamianFierce: The effort to delay the medical device tax has picked up some Democratic support. Report | Follow @DamianFierce

> Japan's regulators approve Thoratec's HeartMate II pump. News

> India lures med tech manufacturing interest. Story

> Covidien's blood monitor will ship with GE's infant warmers. Item

Biotech Research News

> New molecule opens door to lymphoma combination therapy. News

> Seattle Genetics' next-gen antibody-drug conjugate tackles leukemia in the lab. Report

> Preclinical data snags GlaxoSmithKline's attention in $335M cancer immunotherapy deal. Article

> MicroRNAs could heal broken hearts. Item

Pharma Manufacturing News

> Novo selling Bangladeshi-made insulin after plant fires up. Story

> Congress investigating compounding pharmacy trade group. Item

> Endo reports oversized problem with oversized pain meds. Article

> Pharma files lawsuit against California drug disposal law. News

And Finally… Investigators at the University of Michigan and Harvard have been probing an anti-aging gene that suppresses cancer growth. Story


Suggested Articles

The delay will enable Anixa to perform additional genetic engineering intended to boost the efficacy of the treatment in ovarian cancer.

The new parliamentary arithmetic gives Boris Johnson the numbers to pass the withdrawal agreement and take the U.K. out of the EU.

The discovery that 500 cancers can be slotted into 10 subtypes, each of which is driven by a common set of proteins, could inspire new therapies.